Metacognition Assessment in Patient With Multiple Sclerosis

University Hospital, Grenoble80 enrolled

Overview

This study will assessed the level of consciousness of MS patients suffering of cognitive and motor disorders. Understanding the awareness of the disease is crucial to allow better management of these patients. It has been shown, for other neurological pathologies, that a lack of awareness of deficits leads to inefficient rehabilitation and a disorder of understanding the impact of deficits in daily activities. Metacognition could be altered with age, so we will include participants between 18 and 60 years old.

Subject who have to do neurological assessement by the Multiple sclerosis Functional Composite (MSFC) will be enrolled. The patient will estimate the time to undergo the test. This time will be compared to the time really make by the patient to realise test.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Multiple Sclerosis

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosis of multiple sclerosis * Voluntary for participate to study Exclusion Criteria: * Neurological disease other than Multiple Sclerosis * psychiatric disease, other than depressiveness * illicit substance abuse * Persons referred to in Articles L1121-5 to 8 of the French Public Health Code

Locations (1)

Chu Grenoble Alpes

Grenoble, France

Outcomes

Primary Outcomes

Metacognitive precision

Metacognitive precision based on Multiple Sclerosis Functional Composite (MSFC) score

Time frame: Day 1

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.